Safety and Efficacy of Allogeneic Umbilical Cord Mesenchymal Stem Cell Therapy in Diabetic Nephropathy Patients: A Clinical Trial

Clinical trial NCT07396155 · RECRUITING

Trial details

NCT number: NCT07396155
Sponsor: PT. Prodia Stem Cell Indonesia
Status: RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Diabetic Nephropathy Type 2

Start date: 2026-07-01
Primary completion: 2027-07-01
Enrollment: 10

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.